[{"bbox": [90, 98, 370, 132], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [97, 179, 774, 216], "category": "Caption", "text": "Chart 17: Market Share by Application Usability - CY 2024"}, {"bbox": [99, 242, 1358, 858], "category": "Picture"}, {"bbox": [97, 858, 617, 888], "category": "Text", "text": "Source â€“ Imarc Research, CareEdge Research"}, {"bbox": [89, 924, 1561, 1121], "category": "Text", "text": "The India In-Vitro Diagnostics (IVD) market, when segmented by application, is mainly driven by the infectious disease segment, which accounts for 45% of the market in CY24, reflecting its critical role in disease detection and management. Diabetes and cardiology follow with 10% and 9% shares, respectively, highlighting the growing demand for diagnostic solutions in managing chronic diseases. Cancer/oncology, nephrology, and autoimmune diseases contribute 8%, 7%, and 6%, respectively, underscoring the need for advanced diagnostic tools in specialized medical fields. The remaining 15% falls under other applications, demonstrating the broad scope of the IVD market."}]